Survodutide 10mg (10 Vials / Kit)

Survodutide at a glance

Survodutide is a synthetic, lipidated peptide developed by Boehringer Ingelheim, with discovery origins in a collaboration with Zealand Pharma. Its sequence is engineered so the molecule activates two receptors at once, the glucagon receptor and the GLP-1 receptor, while a fatty-acid side chain extends its time in circulation. It belongs to a growing class of multi-receptor incretin-type peptides and is distinct from GIP-containing agonists such as tirzepatide.

Price and availability

Sold by Uther Peptide and sent from China, this listing is a kit of 10 vials at 10mg each (100 mg in total). The price is $230.00, or $2.30 per milligram of peptide. 4 brands sell Survodutide on GLP1 Forum Escrow, with a typical price of $2.10–$2.30 per mg (median $2.30); this listing is inside that range. Your payment waits in escrow until you confirm the parcel arrived, and only then is it released to the brand.

What it is studied for

Two receptor actions are combined in one molecule. GLP-1 receptor signaling is studied for reduced food intake, slower gastric emptying and glucose-dependent insulin release. Glucagon receptor signaling, concentrated in the liver, is examined for increased fatty-acid oxidation, reduced hepatic fat and higher energy expenditure, although on its own it tends to raise blood glucose. The GLP-1 component is thought to offset that glycemic effect. The balance between the two activities is a key design variable, and how much each contributes to observed outcomes is still being characterized.

Research and regulatory status

Phase 2 trials in obesity and in metabolic dysfunction-associated steatohepatitis reported reductions in body weight and liver fat compared with placebo, with gastrointestinal effects as the most common adverse events. Phase 3 programs in obesity and liver disease are under way. Survodutide has no regulatory approval, its long-term safety profile is still being established, and research-grade material has no connection to the sponsor's clinical supply.

Checking the lab data

Mass spectrometry should show the intact mass of the lipidated peptide, confirming that the fatty-acid side chain is present, since a peak at the bare-backbone mass would point to a synthesis problem. HPLC purity should be reported with a chromatogram, as closely related sequence and acylation impurities are common for this class. Peptide content per vial and a white, uniform lyophilized cake are also expected.

This listing has an independent lab report attached; the testing panel above summarises what the tested sample contained against its label.

Listing details

Compound

Survodutide

Synonyms

BI 456906

Class

Investigational dual glucagon/GLP-1 receptor agonist

Format

Lyophilized (freeze-dried) powder

Vial strength

10mg

Vials per kit

10

Total content

100 mg

Price per mg

$2.30

Sold by

Uther Peptide

Ships from

China

Lab report

Independent report attached

Storage and preparation

Keep unopened freeze-dried vials cold, sealed and out of the light; moisture is what degrades a lyophilized cake fastest. After reconstitution, refrigerate the solution and work within the stability window your protocol sets.

Concentration arithmetic: one 10 mg vial dissolved in 2 mL gives 5 mg/mL, or 10 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.